We are live on
!
Find out more
First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
19 hedge funds and large institutions have $7.04M invested in First Trust Nasdaq Pharmaceuticals ETF in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
14% more capital invested
Capital invested by funds: $6.18M → $7.04M (+$858K)
6% more funds holding
Funds holding: 18 → 19 (+1)
1.03% more ownership
Funds ownership: 43.84% → 44.87% (+1%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
+$219K |
| 2 |
SC
Steph & Co
Marinette,
Wisconsin
|
+$136K |
| 3 |
AIP
Ameritas Investment Partners
Lincoln,
Nebraska
|
+$41.4K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$27.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$22.1K |
